Skip to content

MDMA: all studies

Page 28 of 352: studies 271 to 280 of 3,514, newest first. Back to the MDMA overview

Research

MDMA Therapy for PTSD: Inching Closer to—or Farther From—Approval?

The Senior Care Pharmacist July 31, 2024 Leigh Davitian 1 citation

In recent years, scientists have initiated a renaissance in psychedelic research following decades of prohibition. Compounds such as ketamine, LSD, and psilocybin 'once primarily associated with recreational use' are now being investigated for their therapeutic potential, with promising results. An estimated 40-60% of people with post-traumatic stress disorder (PTSD) do not respond to selective...

Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile “the great entactogen—empathogen debate”

Journal of Psychopharmacology July 28, 2024 Kurt Stocker, Matthias E. Liechti 15 citations

Science on methylenedioxymethamphetamine (MDMA) and MDMA-like substances is faced with the unique situation that this class of psychoactive agents is referred to with two basic names for its effects on the mind: empathogens and entactogens. Empathogen usually refers to the prosocial, empathetic, and openness properties of MDMA, while entactogen usually refers to the introspective and...

DOI: 10.1177/02698811241265352 (opens in new tab) MDMA Ecstasy Introspection Openness to experience +3

Critical review of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for posttraumatic stress disorder: Unanswered questions and future directions

Journal of Psychedelic Studies July 18, 2024 Alex P. Hood, Chris E. Corlett, Cameron T Alldredge et al. 1 citation

AbstractBackground and AimsPost-Traumatic Stress Disorder (PTSD) is a debilitating condition that affects a sizable proportion of U.S. civilians, military personnel, and veterans. 3,4-Methylenedioxymethamphetamine-Assisted Therapy (MDMA-AT) is a novel treatment approach for PTSD that has both stirred media enthusiasm and drawn criticism. This critical review analyzes individual randomized,...

Ecstasy-Induced Rhabdomyolysis Leading to Severe Acute Kidney Injury Requiring Temporary Hemodialysis: A High Risk for Recurrence With Repeated Exposure.

Cureus July 1, 2024 Sabastain F Forsah, Bibi Razak, Divine Besong Arrey Agbor et al.

Ecstasy (3,4-methylenedioxymethyl-amphetamine, MDMA) is an illicit drug that has found widespread use. It is mostly used by adolescents and young adults, particularly during intense and prolonged dance parties for its mood-enhancing properties. Despite these pleasurable effects, users may have potentially serious side effects including death. One of the serious side effects is rhabdomyolysis,...

DOI: 10.7759/cureus.64010 (opens in new tab) Full text (opens in new tab) Molly Drug use Hemodialysis Methylenedioxymethyl-amphetamine +6

Examining the Role of Oxytocinergic Signaling and Neuroinflammatory Markers in the Therapeutic Effects of MDMA in a Rat Model for PTSD.

Pharmaceuticals June 27, 2024 Haron Avgana, Roni Shira Toledano, Irit Akirav 8 citations

MDMA-assisted psychotherapy has shown potential as an effective treatment for post-traumatic stress disorder (PTSD). Preclinical studies involving rodents have demonstrated that MDMA can facilitate the extinction of fear memories. It has been noted that MDMA impacts oxytocin neurons and pro-inflammatory cytokines. Thus, the aim of this study was to explore the role of oxytocinergic signaling...

Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis.

Scientific Reports June 26, 2024 Lukas A Basedow, Tomislav Majić, Nicklas Jakob Hafiz et al. 13 citations

Classic psychedelics and MDMA have a colorful history of recreational use, and both have recently been re-evaluated as tools for the treatment of psychiatric disorders. Several studies have been carried out to assess potential long-term effects of a regular use on cognition, delivering distinct results for psychedelics and MDMA. However, to date knowledge is scarce on cognitive performance...

Bile acids and the gut microbiome are involved in the hyperthermia mediated by 3,4-methylenedioxymethamphetamine (MDMA).

Scientific Reports June 24, 2024 Srishti Rana, Jeremy R Canfield, Christopher S Ward et al. 5 citations

Hyperthermia induced by phenethylamines, such as 3,4-methylenedioxymethamphetamine (MDMA), can lead to life-threatening complications and death. Activation of the sympathetic nervous system and subsequent release of norepinephrine and activation of uncoupling proteins have been demonstrated to be the key mediators of phenethylamine-induced hyperthermia (PIH). Recently, the gut microbiome was...

Reaction mixed over FDA committee rejection of MDMA therapy for PTSD

Mental Health Weekly June 14, 2024 Valerie A. Canady

A recent decision by the U.S. Food and Drug Administration's (FDA) advisory committee to reject psychedelic treatment and therapy to treat post‐traumatic stress disorder (PTSD), citing that the available evidence of midomafetamine, better known as MDMA, fails to show that the drug is effective, has been met with mixed reaction by a member of the field and an advocacy organization committed to...

Driving under the influence of cocaine and MDMA: Relationship between blood concentrations and results from clinical test of impairment.

Journal of Analytical Toxicology June 11, 2024 Gunhild Heide, Ragnhild Elén Gjulem Jamt, Jonas Fainberg-Sandbu et al. 8 citations

The general use of cocaine is increasing in recent years, while the trend for 3,4-methylenedioxymethamphetamine (MDMA) is less clear. The relationship between blood concentrations and impairment is poorly understood, which complicates interpretation. The aims of this study were to report prevalence and blood concentrations of cocaine and MDMA in drugged drivers, and to investigate the...

DOI: 10.1093/jat/bkae024 (opens in new tab) Full text (opens in new tab) MDMA Drug testing Impaired driving Traffic safety +1

Psychoactive Drug MDMA

Journal of Community Pharmacy Practice June 10, 2024 Amit Prasad Rath

MDMA, commonly known as ecstasy or molly, is a synthetic psychoactive drug with a complex history. It produces feelings of increased empathy, emotional connection, and heightened sensory perception. While recreational use of MDMA has been prevalent, recent research suggests significant therapeutic potential in treating mental health conditions like post-traumatic stress disorder (PTSD). This...